Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.2K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.2K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

2.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.3K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

5.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.2K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyramid contrastive learning for clustering.

Neural networks : the official journal of the International Neural Network Society·2025
Same author

SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events.

Radiology·2025
Same author

Metabolic cardiomyopathy associated with a compound heterozygous variant in NAD(P)HX dehydratase: a case report and literature review.

Translational pediatrics·2025
Same author

Comprehensive analysis of the xbp1 gene in Pacific abalone Haliotis discus hannai: Structure, expression, and role in heat stress response.

International journal of biological macromolecules·2025
Same author

A Semi-Supervised Multi-Region Segmentation Framework of Bladder Wall and Tumor with Wall-Enhanced Self-Supervised Pre-Training.

Bioengineering (Basel, Switzerland)·2025
Same author

Overexpression of apple MdNRT1.7 enhances low nitrogen tolerance via the regulation of ROS scavenging.

International journal of biological macromolecules·2025

Related Experiment Video

Updated: Feb 26, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.9K

AMPAkines and morphine provide complementary analgesia.

Yongjun Sun1, Kevin Liu2, Erik Martinez2

  • 1Department of Anesthesiology, Hunan Cancer Hospital, Hunan Provence, China.

Behavioural Brain Research
|July 24, 2017
PubMed
Summary

AMPAkines enhance pain relief when combined with opioids like morphine. This study shows AMPAkines provide additional analgesia, even when administered directly into the brain, complementing opioid treatments.

Keywords:
AMPAkinesAnalgesiaMorphinePrefrontal cortex

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.2K
Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

2.8K

Related Experiment Videos

Last Updated: Feb 26, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.9K
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.2K
Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

2.8K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Management

Background:

  • Glutamate signaling is crucial for central nervous system pain regulation.
  • AMPAkines modulate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors to enhance glutamate signaling.
  • Previous research indicates AMPAkines possess analgesic properties, likely acting within the brain.

Purpose of the Study:

  • To investigate if AMPAkines can provide complementary analgesia when co-administered with opioids.
  • To determine the efficacy of AMPAkines in both naive and post-operative pain models.
  • To explore the potential of direct prefrontal cortex administration of AMPAkines for pain relief.

Main Methods:

  • Co-administration of an AMPAkine with morphine in rat models.
  • Assessment of analgesia in naive rats and rats with postoperative pain.
  • Direct infusion of AMPAkine into the prefrontal cortex.

Main Results:

  • Co-administration of AMPAkine and morphine produced additive analgesia in both naive and postoperative pain models.
  • Direct prefrontal cortex administration of AMPAkine resulted in analgesia.
  • Prefrontal AMPAkine infusion enhanced morphine's analgesic effects, complementing opioid therapy.

Conclusions:

  • AMPAkines can provide complementary analgesia to morphine, a commonly used analgesic.
  • The prefrontal cortex is a viable site for AMPAkine administration to achieve pain relief.
  • Combining AMPAkines with opioids offers a promising strategy for enhanced pain management.